share_log

BTIG Initiates Coverage On Xtant Medical Hldgs With Buy Rating, Announces Price Target of $2

BTIG Initiates Coverage On Xtant Medical Hldgs With Buy Rating, Announces Price Target of $2

BTIG以買入評級啓動對Xtant Medical Hldgs的保險,宣佈目標股價爲2美元
Benzinga ·  2023/12/05 08:40

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Target of $2.

BTIG分析師瑞安·齊默爾曼以買入評級開始對Xtant Medical Hldgs(AMEX: XTNT)進行報道,並宣佈目標股價爲2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論